Welcome to our dedicated page for Cresco Labs news (Ticker: CRLBF), a resource for investors and traders seeking the latest updates and insights on Cresco Labs stock.
Cresco Labs Inc. (CRLBF) generates a steady flow of news related to its cannabis cultivation, production, branded products and Sunnyside retail dispensaries. As a company that emphasizes a CPG approach to national cannabis brands and a customer-focused retail experience, its announcements often highlight new store openings, market entries and updates on financial performance.
Readers of this news feed can expect coverage of dispensary openings and expansions, such as new Sunnyside locations in regulated medical marijuana and adult-use markets. These stories typically describe how each store fits into Cresco Labs’ broader national footprint and its efforts to provide an educational, approachable retail environment for patients and consumers.
The company also issues financial and operating results updates, including quarterly earnings releases that outline revenue, gross profit, net income or loss and non-GAAP metrics like Adjusted EBITDA and Adjusted gross profit. These releases are often paired with information about conference calls and webcasts for investors, as well as references to related filings on SEDAR+ and EDGAR.
Another key category of Cresco Labs news involves capital structure and financing. The company has announced commitments and closings for senior secured term loan refinancings, describing how these transactions affect its debt profile, maturity schedule and financial flexibility.
Policy and regulatory developments also appear in the news flow. Cresco Labs has commented on significant changes in U.S. cannabis regulation, including federal rescheduling actions, and has framed these events in the context of its mission to normalize and professionalize the cannabis industry. For investors and observers, following CRLBF news provides insight into how the company is expanding its brand portfolio, managing its balance sheet and responding to evolving cannabis laws.
Sean 'Diddy' Combs has signed agreements to purchase New York, Illinois, and Massachusetts assets from Cresco Labs (CNSX:CL) and Columbia Care (NEO:CCHW). This transaction, valued at up to US$185 million, marks Combs' entry into the cannabis industry and will create the largest Black-owned cannabis company in the world. The deal is a significant step towards Cresco's acquisition of Columbia Care, enhancing their market presence in major cities like New York City, Chicago, and Boston.
Cresco Labs (CSE:CL, OTCQX:CRLBF) will report its financial results for Q3 2022 on November 15, 2022, before market open. A conference call will follow at 8:30 AM EST to discuss the results and key business highlights. Cresco Labs is recognized as the largest U.S. wholesaler of branded cannabis products, employing a consumer-packaged goods approach. The company focuses on enhancing the cannabis industry through consumer education and social equity initiatives.
Cresco Labs (OTCQX:CRLBF) announced the immediate resignation of board director Sidney Dillard, who is joining a national health insurance provider to avoid regulatory conflicts. CEO Charles Bachtell expressed disappointment over her departure but acknowledged her contributions and emphasized the company's commitment to maintaining diverse leadership. Dillard expressed gratitude for her time at Cresco and shared optimism for the company's future. Cresco Labs is a leading U.S. cannabis wholesaler, known for its diverse array of trusted brands and initiatives focused on social equity within the industry.
Cresco Labs (CSE:CL, OTCQX:CRLBF) has announced the opening of its second Sunnyside dispensary in Pensacola, Florida, expanding its retail presence in the Florida Panhandle. This new location is the Company’s 54th nationwide. Despite challenges posed by Hurricane Ian, which affected store operations, Cresco has reopened its facilities and continues to serve Florida patients with medical cannabis. The Company is also engaged in community support initiatives, including food and water drives, to aid recovery efforts.
Cresco Labs announces its expansion into Florida, marking the launch of its flagship brand, Cresco, in its ninth market. The introduction includes a selection of Live Resin products available exclusively at Sunnyside dispensaries. The brand, known as the top-selling vape and concentrate brand in the U.S., aims to enhance product diversity for Florida patients. Cresco's Liquid Live Resin utilizes a patented extraction process that captures the strain's full-spectrum effects, making it a unique offering in the market.
Cresco Labs (CSE:CL, OTCQX:CRLBF) has successfully completed a sale-leaseback transaction for its Brookville, PA property, raising $45 million in non-dilutive funding. The property, which spans approximately 135,000 square feet, will continue to be operated by Cresco's subsidiary, Cresco Yeltrah, under a long-term lease with Aventine Property Group. CEO Charles Bachtell highlighted that this transaction unlocks valuable capital, enhancing their ability to invest in high-return opportunities, particularly in light of the forthcoming Columbia Care acquisition.
Cresco Labs (OTCQX: CRLBF) has expanded its Sunnyside retail brand in Florida with three new dispensaries located in Cape Coral, Tampa, and Panama City Beach. This addition increases Cresco's network to 19 stores in Florida and 53 nationwide. With nearly 750,000 qualified patients and over $2 billion in market revenue, Florida presents a significant growth opportunity. Further store openings are planned for late 2022 and early 2023, aiming to solidify Cresco's leading position in the cannabis market.
Cresco Labs reported a 4% year-over-year revenue growth of $218 million for Q2 2022, alongside an 11% increase in adjusted EBITDA to $51 million, reflecting resilience amid market challenges.
The company maintains its leadership as the no. 1 U.S. wholesaler of branded cannabis products, achieving a 53% adjusted gross margin.
It also noted progress in the ongoing acquisition of Columbia Care, anticipating a year-end closing. Cash on hand stood at $90 million as of June 30, 2022.
Cresco Labs (OTCQX: CRLBF), a leading U.S. wholesaler of cannabis products, has announced that Parkway Dispensary and Navāda Labs have received conditional adult-use dispensary licenses in Illinois. This follows the issuance of 185 new licenses aimed at promoting inclusivity in the cannabis industry. Cresco's SEED initiative has played a vital role in assisting social equity applicants throughout the process. Currently, Illinois has 110 dispensaries, and the new licenses will significantly increase access to cannabis products for consumers.
Cresco Labs (CSE:CL, OTCQX:CRLBF), a leading U.S. cannabis wholesaler, will announce its Q2 2022 financial results on August 17, 2022, before market opening. The company plans to hold a conference call at 8:30 AM EST to discuss the results and key business highlights. After the event, an archive of the webcast will be available for one year on the Cresco Labs investor relations website. Cresco Labs aims to normalize the cannabis industry while operating the largest social equity and educational initiative in the sector.
FAQ
What is the current stock price of Cresco Labs (CRLBF)?
What is the market cap of Cresco Labs (CRLBF)?
